Skip to main content
Achyut Healthcare Limited logo

Achyut Healthcare Limited — Investor Relations & Filings

Ticker · 543499 ISIN · INE0K1401020 BSE.NS Manufacturing
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-05-28 Report Publication Anno…
Country IN India
Listing BSE.NS 543499

About Achyut Healthcare Limited

http://www.achyuthealthcare.com

Achyut Healthcare Limited focuses on the procurement, trading, and manufacturing of pharmaceutical components and finished dosage forms. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), chemical intermediates, and a variety of finished formulations including tablets, capsules, and oral liquids. Operations are centered on maintaining rigorous quality standards and optimizing supply chain logistics to facilitate the distribution of therapeutic products. The organization utilizes technical capabilities in formulation development and chemical sourcing to address diverse medical needs, catering to a broad network of healthcare entities and distribution partners.

Recent filings

Filing Released Lang Actions
Paper Cutting of Published Audited Financial Result for the Quarter and Year ended 31st March, 2026
Report Publication Announcement Classification · 92% confidence The document is a letter from Achyut Healthcare Limited to the stock exchange under SEBI LODR Regulation 30, enclosing photocopies of newspaper cuttings where the audited financial results were published. It does not contain the financial results themselves, only an announcement that they were published (and attachments of paper cuttings). This matches the definition of a Report Publication Announcement (RPA).
2026-05-28 English
Submission of Statement of Deviation or Variation for proceeds of public issue pursuant to Regulation 32 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 for ....
Regulatory Filings Classification · 88% confidence The document is a compliance disclosure filed under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) 2015, providing a statement of deviation/variation in the use of IPO proceeds for the half year ended 31 March 2026. It does not contain financial statements, management analysis, or election information. It is a regulatory announcement to the stock exchange, falling into the general Regulatory Filings category.
2026-05-27 English
Outcome of Board Meeting General update
Earnings Release Classification · 85% confidence The document is a compliance filing under SEBI LODR Regulations 30 and 33 announcing the Board’s approval of the audited financial results for the quarter and full year ended March 31, 2026, and attaches the financial results (P&L statement, notes, Ind-AS reconciliations). It is not a full Annual Report (10-K) nor a proxy/material for shareholders’ meeting, but rather the initial public announcement of periodic financial results, i.e., an Earnings Release. FY 2026
2026-05-27 English
Appointment of Internal Auditor for the Financial Year 2026-27 Pursuant to Regulation 30 of the SEBI (LODR) Regulation, 2015.
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure under SEBI LODR Regulation 30 informing the stock exchange of a material event (appointment of the internal auditor). It does not contain financial statements, voting results, or call transcript; nor is it a full report, proxy, or dividend notice. It is a compliance announcement submitted to the exchange and fits the ‘Regulatory Filings’ category (RNS).
2026-05-27 English
Standalone Audited Financial Result for the quarter and year ended on 31.03.2026
Interim / Quarterly Report Classification · 82% confidence The document is a formal SEBI (Listing Obligations and Disclosure Requirements) Regulation 33 filing to BSE disclosing and attaching the audited financial results for the quarter and year ended March 31, 2026, including full income statement, balance sheet data, notes and reconciliations under Ind AS. It is not a brief earnings highlight (ER), nor a full annual report (10-K), but rather the statutory periodic financial report with substantive data for quarter and year as required under Indian listing regulations. Therefore, it falls under an Interim/Quarterly Report. FY 2026
2026-05-27 English
Standalone Audited Financial Result for the Quarter and Year ended on 31.03.2026.
Interim / Quarterly Report Classification · 78% confidence The document is a board meeting outcome under SEBI LODR 2015 submitting the approved audited financial results for the quarter and year ended March 31, 2026. It contains the full financial statements, notes (including Ind AS reconciliations), and the auditors’ report – i.e., substantive periodic financial data rather than just highlights or a simple announcement. While it includes the annual audited results, it is styled as the regulated “financial results” release rather than a full annual report (10-K) with narrative sections. The detailed tables and notes make it a comprehensive periodic financial report rather than a mere earnings release. Thus the best fit is “Interim / Quarterly Report (IR)” as the periodic financial disclosure category. FY 2026
2026-05-27 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.